Planned Solutions Inc. Purchases Shares of 430 MetLife, Inc. (NYSE:MET)

Planned Solutions Inc. acquired a new position in shares of MetLife, Inc. (NYSE:METFree Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 430 shares of the financial services provider’s stock, valued at approximately $28,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Synovus Financial Corp grew its position in shares of MetLife by 11.4% in the first quarter. Synovus Financial Corp now owns 17,847 shares of the financial services provider’s stock valued at $1,260,000 after purchasing an additional 1,829 shares during the last quarter. Brighton Jones LLC acquired a new stake in MetLife in the 1st quarter valued at approximately $225,000. Baird Financial Group Inc. increased its position in MetLife by 179.7% in the 1st quarter. Baird Financial Group Inc. now owns 540,081 shares of the financial services provider’s stock worth $37,957,000 after buying an additional 346,999 shares during the period. Zions Bancorporation N.A. lifted its holdings in shares of MetLife by 937.3% during the first quarter. Zions Bancorporation N.A. now owns 5,861 shares of the financial services provider’s stock worth $412,000 after buying an additional 5,296 shares during the last quarter. Finally, Brown Brothers Harriman & Co. boosted its position in shares of MetLife by 114.5% in the first quarter. Brown Brothers Harriman & Co. now owns 3,419 shares of the financial services provider’s stock valued at $240,000 after acquiring an additional 1,825 shares during the period. 89.81% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms recently commented on MET. UBS Group cut their target price on shares of MetLife from $87.00 to $82.00 and set a “buy” rating for the company in a research note on Monday, February 5th. Keefe, Bruyette & Woods reduced their target price on shares of MetLife from $79.00 to $77.00 and set an “outperform” rating for the company in a research note on Thursday, December 7th. The Goldman Sachs Group upgraded MetLife from a “neutral” rating to a “buy” rating and boosted their price target for the company from $70.00 to $80.00 in a research note on Monday, January 8th. Finally, Wells Fargo & Company decreased their price objective on MetLife from $85.00 to $83.00 and set an “overweight” rating on the stock in a report on Tuesday, February 6th. Two equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat.com, MetLife currently has a consensus rating of “Moderate Buy” and an average target price of $77.23.

Read Our Latest Analysis on MetLife

MetLife Stock Performance

Shares of NYSE:MET opened at $74.11 on Friday. The stock has a market capitalization of $53.58 billion, a price-to-earnings ratio of 40.50, a price-to-earnings-growth ratio of 0.56 and a beta of 1.03. The business’s fifty day moving average price is $70.01 and its two-hundred day moving average price is $65.93. MetLife, Inc. has a fifty-two week low of $48.95 and a fifty-two week high of $74.39. The company has a debt-to-equity ratio of 0.53, a current ratio of 0.16 and a quick ratio of 0.16.

MetLife (NYSE:METGet Free Report) last announced its earnings results on Wednesday, January 31st. The financial services provider reported $1.93 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.95 by ($0.02). The firm had revenue of $18.72 billion for the quarter, compared to analyst estimates of $18.07 billion. MetLife had a return on equity of 19.48% and a net margin of 2.36%. As a group, analysts predict that MetLife, Inc. will post 8.81 EPS for the current fiscal year.

MetLife Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, March 14th. Investors of record on Tuesday, February 6th were given a dividend of $0.52 per share. The ex-dividend date of this dividend was Monday, February 5th. This represents a $2.08 dividend on an annualized basis and a yield of 2.81%. MetLife’s dividend payout ratio (DPR) is presently 113.66%.

Insider Activity at MetLife

In related news, insider Ramy Tadros sold 4,026 shares of the company’s stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price of $71.90, for a total transaction of $289,469.40. Following the transaction, the insider now owns 146,981 shares in the company, valued at approximately $10,567,933.90. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In other news, EVP Bill Pappas sold 27,000 shares of the business’s stock in a transaction on Monday, March 18th. The stock was sold at an average price of $72.27, for a total transaction of $1,951,290.00. Following the completion of the sale, the executive vice president now owns 57,768 shares in the company, valued at $4,174,893.36. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Ramy Tadros sold 4,026 shares of the firm’s stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price of $71.90, for a total value of $289,469.40. Following the completion of the transaction, the insider now owns 146,981 shares in the company, valued at approximately $10,567,933.90. The disclosure for this sale can be found here. Insiders own 0.32% of the company’s stock.

About MetLife

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Recommended Stories

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.